Article Versions Notes

Janning M, Kobus F, Babayan A, Wikman H, Velthaus J-L, Bergmann S, Schatz S, Falk M, Berger L-A, Böttcher L-M, et al. Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers. 2019; 11(6):835. https://doi.org/10.3390/cancers11060835

Janning, Melanie, Franca Kobus, Anna Babayan, Harriet Wikman, Janna-Lisa Velthaus, Sonja Bergmann, Stefanie Schatz, Markus Falk, Lars-Arne Berger, Lisa-Marie Böttcher, and et al. 2019. "Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors" Cancers 11, no. 6: 835. https://doi.org/10.3390/cancers11060835

Janning, M., Kobus, F., Babayan, A., Wikman, H., Velthaus, J.-L., Bergmann, S., Schatz, S., Falk, M., Berger, L.-A., Böttcher, L.-M., Päsler, S., Gorges, T. M., O’Flaherty, L., Hille, C., Joosse, S. A., Simon, R., Tiemann, M., Bokemeyer, C., Reck, M., ... Loges, S. (2019). Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers, 11(6), 835. https://doi.org/10.3390/cancers11060835